Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

824
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
824
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Transcription Factors02:16

Transcription Factors

82.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study.

Diabetes care·2026
Same author

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

The Lancet. Primary care·2026
Same author

Higher Body Mass Index Is a Causal Risk Factor for Skin Infections: A Mendelian Randomisation Study Using UK Biobank and FinnGen.

Diabetes, obesity & metabolism·2026
Same author

Distinct patterns of intraoperative hemodynamic behavior and postoperative outcomes after major abdominal surgery.

Journal of clinical anesthesia·2026
Same author

Reducing postoperative pulmonary complications.

BMJ (Clinical research ed.)·2026
Same author

The potential of low-field MRI for global dementia care.

Nature reviews. Neurology·2026

Related Experiment Video

Updated: Feb 9, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K

Type 2 diabetes: A protective factor for COPD?

Louise H Rayner1, Andrew P McGovern2, Julian Sherlock2

  • 1Department of Clinical and Experimental Medicine, University of Surrey, UK; Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.

Primary Care Diabetes
|May 31, 2018
PubMed
Summary
This summary is machine-generated.

People with type 2 diabetes (T2DM) showed a lower incidence of chronic obstructive pulmonary disease (COPD) compared to those without diabetes. This may be linked to healthier lifestyle choices, like smoking cessation, in the T2DM group.

Keywords:
Chronic obstructive pulmonary diseaseElectronic health recordsIncidenceSmoking cessationType 2 Diabetes mellitus

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Related Experiment Videos

Last Updated: Feb 9, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Area of Science:

  • Pulmonary Medicine
  • Endocrinology
  • Epidemiology

Background:

  • Type 2 diabetes (T2DM) and chronic obstructive pulmonary disease (COPD) are frequently co-occurring conditions.
  • While COPD is a known risk factor for T2DM, the inverse relationship is less understood.
  • This study investigates the incidence of COPD in individuals with and without T2DM.

Purpose of the Study:

  • To compare the incidence of COPD in patients with T2DM versus those without.
  • To explore the impact of T2DM on the development of COPD.

Main Methods:

  • Retrospective case-control study utilizing a large English general practice database (n=894,646).
  • Matched 29,217 T2DM cases with controls using 1:1 propensity matching, adjusting for age, gender, smoking status, BMI, and social deprivation.
  • Followed participants for eight years to compare incident COPD rates and analyzed the effect of specific diabetes medications.

Main Results:

  • Individuals with T2DM had a statistically significant reduced risk of developing COPD (HR 0.89, 95%CI 0.79-0.93).
  • Higher rates of ex-smokers were observed in the T2DM group (48.5%) compared to controls (27.3%).
  • Insulin, metformin, and sulfonylureas showed no association with incident COPD.

Conclusions:

  • T2DM patients exhibit a lower likelihood of COPD diagnosis compared to matched controls.
  • Positive lifestyle modifications, particularly smoking cessation, may contribute to this reduced risk in the T2DM population.